02.17.26 -- Strengthening Quality, Safety & Capacity In Sterile Injectables

Sterile injectable manufacturing demands built‑in contamination control, rigorous monitoring, skilled personnel, and robust quality systems, far beyond sterility testing, to ensure safety, compliance, and reliable CDMO performance.

This presentation highlights how simplified execution with development, filling, and analytics under one roof ensures safe, efficacious products reach patients in need.

Discover how proven sterile fill-finish expertise, high-potency capabilities, and customizable cleanrooms can support your product from development to commercialization.

Our 87,000 sq. ft. cGMP-certified drug product manufacturing facility, located in Baltimore, Maryland, offers aseptic fill/finish manufacturing of biologics and sterile injectables.

Investment strengthens our leadership position in sterile fill / finish and expands the company’s aseptic drug product manufacturing capabilities in pre-filled syringes and cartridges.

Drive compliance, sterility assurance, and manufacturing efficiency by leveraging the proven advantages of terminal sterilization for your drug products.

Sterile fill/finish requires isolator technology and regulatory compliance. From clinical development to commercial scale, technical expertise ensures the integrity of injectables.

With decades of experience, we offer a flexible and collaborative partnership model for manufacturing excellence that enables our clients to increase speed to market with full regulatory confidence.

Watch as Senior Key Account Manager, Dr. Jürgen Lübbehusen highlights the overall fill-finish capabilities and capacities, with a focus on our ability to help meet your complex needs.

Explore our fill line capabilities, including vial and syringe handling. Schedule an immersive tour of our drug product filling facility in Denmark. Our experienced team is available to discuss your needs.